Daily Brief Archive: July 8, 2026 — U.S. & Hong Kong Stock Analysis

Free preview

U.S. Markets

  • Chips sold again: Samsung's print missed the loftiest bar and DeepSeek's own-chip report hit — Nasdaq -1.2%
  • S&P -0.45% to 7,503.85, SMH down 3%+ as pricey AI names see profit-taking
  • Iran hit a tanker near Hormuz: Brent +3% to $74.16, energy led with XLE +2.8%
  • Rivian's 75M-share, $1.5B offering triggered an 18% dilution rout
  • Vertex's $10B all-cash Crinetics buyout ($85/share) stokes the biotech M&A wave

Hong Kong

  • HK opened soft and closed broadly higher, HS Tech leading; Tencent up seven straight
  • Beaten-down internet repairs: Alibaba, Xiaomi and Kuaishou all up 2%+ early
  • Domestic-compute narrative builds: Meituan's LongCat-2.0 trained fully on local silicon; Biren +10%
  • UBTECH fell another 5.8% as the robotics cool-down continues
  • The tanker attack lifted energy; the big-three Chinese oils bounced from oversold

Today's Watchlist

  • SK Hynix lists on Nasdaq Jul 10 — memory-trade money faces reallocation
  • Tesla earnings Jul 22 and AMD's Advancing AI Jul 23 — two judgment days
  • If DeepSeek's own chip is confirmed, the AI-compute narrative gets rewritten
  • Hormuz heats up: the fragile US-Iran truce amplifies oil volatility
  • SpaceX -6.8% the day after inclusion — the 'inclusion marks the top' pattern strikes again

Deep Dives (7 names)

Neutral
Score6/10RSI(14) 50.4Offering size 75M shares / $1.5BOne-day drop -18.1%Position closed Stopped out -11.5%

Technicals — Down 18.1% to $16.49 — the worst day since 2024 — giving back nearly all of last week's 27% run. Barely holding the 20-day ($16.34) on 2.5x volume; real supply. Until the offering prices, upside is capped, with the 50-day ($15.6) the next support.

Fundamentals — The 75M-share, ~$1.5B raise funds equity contributions under its DoE loan (the Georgia plant) — strategically sound, near-term pure dilution. The pre-released Q2 revenue of $1.55–1.65B and raised guidance got drowned out. The fundamental direction is intact, but ~6% more shares directly dilutes per-share value.

News — The public offering announced intraday on 7/7 drove the crash — worst day since 2024, fifth-worst ever. It came one day after an 8.1% delivery-driven pop: shrewd timing (raising at highs), brutal for retail. Bloomberg and CNBC both point to the DoE loan equity-contribution use.

Short-term · 1–3 weeks
Neutral Sidelines

Position stopped out (-11.5%): the offering shattered the momentum thesis, and bids won't return until it prices. This is a discipline exit — the delivery story survives, but let the dilution digest first. Reassess on a post-pricing volume dry-up.

Entry Revisit after the offering prices and volume dries up; watch the 50-day near $15.6Stop $14.8Target $19
Long-term · months+
Neutral

The R2 ramp plus DoE-backed capacity expansion is a real growth path, but recurring capital needs make dilution the rule, not the exception. Wait for the offering to digest and Q2 to confirm the margin trajectory before a long-term case.

  • Offering overhang plus further capital needs ahead
  • EV demand swings make delivery momentum fragile
  • Tesla price cuts and competition squeeze margins
Community Voices
  • StockTwits · Yesterday's cheerleaders are today's mourners — the company hands you a share offering at peak euphoria; that's the market's sense of humorOriginal ↗
Institutional Views
  • 华尔街共识 · 27 analysts, average target $18.6 (+13% vs. spot), rating 1.74 — targets face a post-dilution reset
  • CNBC · Proceeds fund equity contributions under the DoE loan agreement, feeding the Georgia plant buildoutSource ↗
Neutral
Score6/10Deal price $85.00Acquirer VertexDeal size ~$10B all cashArb spread +1.8%

Technicals — Up 98.7% to $83.53 on 39x volume, pinned 1.8% below the $85 deal price — no longer a chart-driven stock, it's an arb instrument. Into the Q3 close it grinds toward $85, absent a topping bid or a deal break.

Fundamentals — Vertex pays $85/share in cash, ~$10B total, unanimously approved by both boards, closing in Q3. The strategic core: Palsonify for acromegaly and pipeline asset atumelnant (potential $5B+ peak sales), extending Vertex into rare endocrine disorders.

News — The deal hit pre-market 7/7 and the stock repriced in one step. It's the largest print of this biotech M&A wave — IBB just made 52-week highs (RSI 81) as big pharma sweeps late-clinical assets for cash, and the sector's 'who's next' guessing game is on.

Short-term · Into the Q3 close
Neutral Sidelines

The deal price caps the upside; the residual spread compensates deal-break risk — professional arb territory. Holders can ride to close or cash out now; fresh money has no reason to enter.

Entry Nothing here for retail: the 1.8% spread is arb-fund business, not a tradeStop —Target $85
Long-term · months+
Neutral

The company gets absorbed into Vertex in Q3 — the standalone story ends here. The real takeaway is sector-level: cash-rich pharma is sweeping, and late-clinical, pre-commercial mid-caps fit this M&A wave's prey profile.

  • A deal break gives back most of the gain (unlikely but real)
  • Regulatory review drags the close
Community Voices
  • StockTwits · Yesterday's holders are popping champagne; today's buyers are annualizing 1.8% — same ticker, two different livesOriginal ↗
Institutional Views
  • 交易条款 · $85/share all cash, ~$10B, unanimously board-approved, expected to close in Q3 2026Source ↗
  • Seeking Alpha · Atumelnant's $5B+ peak-sales potential is the core chip behind Vertex's moveSource ↗
Long
Score7/10RSI(14) 49.6Off 52w high -19.2%P/E (TTM) 368Position P/L Long since 7/4, +2.4%

Technicals — Down 4% to $402.9, surrendering the just-reclaimed 200-day ($418.5) and barely holding above the 20-day ($399.8). The robotaxi thrust gave back most of itself in a day, turning $399–418 back into a meat grinder. RSI 49.6 neutral; direction stays unresolved into the 7/22 print.

Fundamentals — The +25% Q2 deliveries and Miami robotaxi are priced; at 368x the market now interrogates 7/22 margins and robotaxi economics. Rivian's dilution rout soured the whole EV tape, and richly valued growth had nowhere to hide on a chip-selloff day.

News — No fresh stock-specific negative — the pullback is the EV sentiment hit from Rivian's raise compounding the broader tech selloff. Robotaxi remains 'an early milestone' in the market's framing; the 7/22 print is the valuation courtroom.

Short-term · 1–3 weeks
Long Lean bullish

Keep the long but downgrade to lean bullish: the failed 200-day reclaim weakens the trend signal, with the 20-day ($399.8) and the $390 stop as twin defenses. Hold them and there's room to repair into earnings; below $390, exit unconditionally — don't gamble the print.

Entry $395–405, stabilizing above the 20-dayStop $390Target $440
Long-term · months+
Neutral

Deliveries back in growth plus storage plus the robotaxi/Optimus options are a real story; 368x is a real price. Keep a core for the optionality, save size for valuation craters — the market reteaches this lesson quarterly.

  • A margin miss on 7/22 puts the multiple on trial
  • Robotaxi expansion lags the narrative
  • EV sentiment whiplash (the Rivian-raise hangover)
Signal BacktestCumulative -4.02%price itself -5.27%
  • 07-07Long$419.77 → open → $402.9-4.02%
Community Voices
  • StockTwits · Yesterday's $420 chasers are now lecturing about 'the long view' — nothing teaches value investing faster than being underwaterOriginal ↗
Institutional Views
  • 华尔街共识 · 50 analysts, average target $404.2 (+0.3% vs. spot), rating 1.77 — price sits on consensus; earnings decide the tie
Long
Score8/10RSI(14) 43.5Off 52w high -16.7%P/E (TTM) 30.2Position P/L Long since 7/4, +1.1%

Technicals — Up 0.7% to $196.93 on a chip-bloodbath day, holding the 200-day ($191.3) a fourth straight session — the rumor targeted its share and it was the most resilient name anyway. That relative strength is the chip tape's most important signal this week. The 20/50-day ($202/$210) still cap.

Fundamentals — The DeepSeek own-chip report was the selloff's bullseye, but this script ran in early 2025: cheaper inference ultimately expands total compute demand. 30x against +70% revenue growth is still the cheapest percentile in a year, with order visibility into 2027.

News — Reuters reported DeepSeek is building its own AI chip to compete with NVIDIA — another entry in the China-inference-localization story. Yet the day's selling hit AMD, Broadcom and Marvell while NVIDIA ticked up: the market voted with its feet on whose moat is deeper. WSB mentions doubled to 219.

Short-term · 1–3 weeks
Long Lean bullish

Keep the long: the bullseye name was the most resilient, with a four-day 200-day hold, bottom-percentile valuation, and doubled mention flow. Clearing the 20-day ($202) opens the repair; below $182, take the loss.

Entry Scale in at $190–197, above the 200-dayStop $182Target $220
Long-term · months+
Accumulate

Pricing power plus the CUDA ecosystem remain unshaken, and the cheaper-inference script has historically expanded total demand. 30x for 70% growth, with sovereign-AI and government orders as the second curve.

  • China inference localization erodes share over time
  • Hyperscaler capex peaks or shifts to in-house ASICs
  • Export-control surprises
Signal BacktestCumulative +1.08%price itself -0.33%profitable since 07-07
  • 07-04Long$194.83 → open → $196.93+1.08%
Community Voices
  • WSB · Mentions doubled in 24h to 219: the target took the shot and didn't fall — the crowd believes harder nowOriginal ↗
Institutional Views
  • 华尔街共识 · 66 analysts, average target $313.4 (+59% vs. spot), rating 1.13 — firmly strong-buy
  • 路透 / 板块 · The DeepSeek chip report triggered the chip selloff, yet NVIDIA closed up on the day — relative strength speaksSource ↗
Long
Score7/10RSI(14) 51.2Off 52w high -11.7%P/E (TTM) 169Position P/L Long since 7/4, -0.3%

Technicals — Down 6.5% to $516.11, giving back yesterday's gain almost exactly and slipping just under the 20-day ($520.8). The uptrend structure holds (the 50-day at $469.6 is far below), but a slope this steep costs you 7%-ATR elevator rides. The $500 round number is the bulls' floor.

Fundamentals — Samsung's print and the DeepSeek chip report double-teamed richly valued AI silicon, and AMD's sector-high beta took the first hit. The MI400 H2 ramp and the 7/23 Advancing AI narrative are unchanged — 169x prices flawless execution, and volatility is simply a property of that multiple.

News — Briefly -7% to $508 on sector profit-taking and 'sky-high expectations vs. straining fundamentals' angst — no stock-specific negative. Into the event, any noise on Helios rack systems or customer commitments gets amplified; the event-driven sword cuts both ways.

Short-term · 1–3 weeks
Long Lean bullish

Keep the long: structure intact, the 7/23 event is a clear catalyst. But tighten the stop to $495 (one buffer below the round number), and don't add — volatility only grows into the event.

Entry Scale at $500–516 above the round number; go heavier on a deep 50-day ($470) retestStop $495Target $585
Long-term · months+
Accumulate

Inference is bigger and longer than training, and the MI400 (432GB HBM4) is the next card in the price-performance play. 2027 earnings can grow into the multiple; deep squats near the 50-day are long-term adds.

  • An underwhelming 7/23 event means a -20%-class de-rate
  • DeepSeek-style in-house chips erode China inference demand
  • Any slip in the MI400 production timeline
Signal BacktestCumulative -6.51%price itself -4.58%
  • 07-07Long$552.05 → open → $516.11-6.51%
Community Voices
  • WSB · The $600 callers yesterday and the $450 callers today are the same people — pre-event bulls and bears are both just echoes of moodOriginal ↗
Institutional Views
  • 华尔街共识 · 59 analysts, average target $515.5 (at spot), rating 1.26 — targets caught up; the raise wave hinges on the event
  • 24/7 Wall St · Samsung's print triggered the chip rout: Intel/AMAT -10%, AMD briefly -8% — rich multiples all on trialSource ↗
Long
Score8/10RSI(14) 46.3Off 52w high -25.2%P/E (TTM) 21.2Position P/L Long since 7/7, -4.7%

Technicals — Down 4.7% to $938.38 as Samsung's print interrupted yesterday's stabilization, but it still trades above the 50-day ($871). RSI 46 neutral; the $880 stop (a buffer above the 50-day) is intact. At a 9% daily ATR this drawdown is within noise — the 50-day at $871 holds the verdict.

Fundamentals — Samsung grew profit 19-fold and still missed the loftiest bar — memory expectations are stretched to the limit, and that, not demand weakness, drove the pullback. UBS's 'undersupplied to 2Q28' and BofA's $1,550 target didn't change in a day. 21x against +167% revenue — a deeper dip just improves the odds.

News — Samsung's print plus the DeepSeek report double-hit memory: Micron -4.7%, SanDisk -7.3%. SK Hynix's 7/10 Nasdaq listing countdown keeps the reallocation question alive. Still #1 on WSB at 681 mentions and warming — retail attention hasn't left.

Short-term · 1–3 weeks
Long Lean bullish

Keep the long: the dip came from stretched expectations, not weakening fundamentals, and the upgrade thesis stands. $880 (a buffer above the 50-day) is the iron stop; the Hynix-listing rotation on 7/10 is a known variable, not a new risk.

Entry Scale in at $900–950, above the 50-dayStop $880Target $1150
Long-term · months+
Accumulate

HBM locked under long-term deals in a cycle tight to 2028, at 21x against triple-digit growth. Memory is 35-40% of cloud AI capex yet trades at 10x forward — the mispricing case gets better as it falls.

  • Samsung/Hynix supply lands early and crushes pricing
  • The Hynix listing siphons the valuation-anchor flow
  • An AI-capex peak de-rates the whole cycle
Signal BacktestCumulative -4.71%price itself -9.10%
  • 07-07Long$984.75 → open → $938.38-4.71%
Community Voices
  • WSB · 681 mentions at #1 and still warming: a 4.7% drop made it louder — memory is this retail cohort's main battlefieldOriginal ↗
Institutional Views
  • 华尔街共识 · 53 analysts, average target $1,576 (+68% vs. spot), rating 1.14 — near strong buy
  • UBS / 美银 · The upgrades stand: DRAM undersupplied to 2Q28, DDR contract pricing +32% QoQ in Q3Source ↗
Neutral
Score6/10Above post-IPO low +1.6%Day after inclusion -6.8%IPO price $135Signal record Closed 7/7 at +1.8%, dodged today

Technicals — Down 6.8% to $149.47 the day after inclusion, within 1.6% of the $147.11 post-IPO low — the 'inclusion marks the top' pattern executed by the book. A $147 break enters price-discovery no-man's-land; a hold could build a double bottom. MAs still haven't formed; events and psychology rule.

Fundamentals — The $4.3B passive bid landed and marked the top as trapped and profit-taking supply distributed together. Fundamentals unchanged: 10.3M Starlink subs with sliding ARPU, $5B annual losses, and a $2.1T cap pricing a flawless decade. Starship flight 13 late this month is the next real catalyst.

News — Yesterday's shift to sidelines (+1.8% banked) preceded today's -6.8% — the 'inclusion top, one-month give-back' pattern struck again. Multiple desks had flagged it; mechanical passive buying is never price's friend.

Short-term · 1–3 weeks
Neutral Sidelines

Stay sidelined: the give-back isn't done, and $147 is the level everyone watches — a hold starts a double bottom, a break fires the next leg down. No need to pick a side before the Starship flight late this month.

Entry Small probe if $147 holds on drying volume; on a break, wait out price discoveryStop $143Target $170
Long-term · months+
Neutral

The launch monopoly and Starlink cash-flow layer are a real moat; $2.1T on $5B losses is a real problem. Until the give-back ends and ARPU stabilizes, wait for a fatter pitch.

  • A $147 break triggers reverse passive rebalancing
  • A Starship flight failure
  • ARPU erosion plus Amazon's LEO competition
Signal BacktestCumulative +1.83%price itself -5.12%1/1 closed trades wonprofitable since 07-04
  • 07-02Long$157.54 → closed $160.4207-07+1.83%
Community Voices
  • WSB · Mentions doubled 79→140 and the dip-buyers are queuing at $147 — the support everyone can see is usually the first to breakOriginal ↗
Institutional Views
  • 华尔街共识 · 31 analysts, average target $246.9 (+65% vs. spot) with positive ratings — coverage got more bullish into the drop
  • The Motley Fool · The inclusion premium historically unwinds over about a month — we're in the give-back leg nowSource ↗

Rapid Scan (24 names)

TickerCloseChangeScoreDirectionOne-line take
RIVN logoRIVNUS$16.49-18.12%6NeutralThe 75M-share raise crushed it -18%; momentum story broken — stopped out at -11.5%
CRNX logoCRNXUS$83.53+98.74%6NeutralVertex's $85 all-cash buyout doubled it; the remaining 1.8% spread is arb-fund food
TSLA logoTSLAUS$402.9-4.02%7LongLost the reclaimed 200-day, -4%; $390 is the bulls' last line — downgraded to lean bullish into earnings
NVDA logoNVDAUS$196.93+0.71%8LongDeepSeek aimed at it and it rose 0.7% anyway; four days on the 200-day, top relative strength
AMD logoAMDUS$516.11-6.51%7LongYesterday +6.6%, today -6.5% — the pre-event elevator; trend intact, hold with the stop tightened to $495
MU logoMUUS$938.38-4.71%8LongSamsung's sneeze cut the bounce, -4.7%; the undersupplied-to-2028 script stands, $880 iron stop
SNDK logoSNDKUS$1,617.7-7.26%6Neutral-7.3% through the 50-day, -23% on the week; memory's weakest link, stay sidelined
SPCX logoSPCXUS$149.47-6.83%6Neutral-6.8% the day after inclusion proves the pattern; yesterday's exit dodged it — $147 is the line
META logoMETAUS$615.58+2.55%7Long+2.6% through the 50-day, long +2.5%; the AI-cloud story was immune on chip-rout day
MSFT logoMSFTUS$388.84+0.54%6Long+0.5% resilient; the 23x laggard in value territory, long +1.1%, hold
DTE logoDTEUS$153.84+1.64%6Long+1.6% near 52-week highs; long flat, WSB buzz surging — defense plus AI power
OXY logoOXYUS$51.68+5.88%6Neutral+5.9%, a top tanker-attack beneficiary; Buffett's floor plus geopolitical premium — no trend yet
NBIS logoNBISUS$195.19-8.37%5Neutral-8.4%, neocloud -24% on the week; even +444% revenue can't stop a de-rate — wait
RKLB logoRKLBUS$83.41-10.40%4Neutral-10.4%, space -27% on the month; SpaceX's slide drags the group — the $76 200-day is the floor
WULF logoWULFUS$20.24-8.87%4Neutral-8.9%, -18% week in the AI-datacenter ebb; high-beta miners fall first — wait for a sector signal
NVTS logoNVTSUS$13.99-8.14%3Neutral-8.1%, -52% on the month; the GaN theme unwinds with no bid — don't touch
PENG logoPENGUS$62.71-7.38%4Neutral-7.4% with the AI-infra pullback; profit-taking after a +189% quarter
FCEL logoFCELUS$25.96-12.68%3Neutral-12.7% as the fuel-cell frenzy ebbs; a +285%-quarter meme's volatility — don't chase
BCRX logoBCRXUS$10.99+8.06%5Neutral+8.1% to 52-week highs; small pharma riding the M&A wave, RSI 72 warm
CMPS logoCMPSUS$12.99+1.17%4Neutral+1.2% psychedelics theme chopping at highs after +129% in a quarter — pure story stock
WEN logoWENUS$7.78-1.52%4Neutral-1.5% with cooling mentions; the 7.1%-yield cigar butt as retail heat fades
POET logoPOETUS$8.27-7.60%3Neutral-7.6%, photonics -43% on the month; the high-beta tail of a fading theme
ABUS logoABUSUS$5.18+4.23%4Neutral+4.2%, the HBV-pipeline small cap at 52-week highs — an M&A-wave fringe name
SSECZUS$8.06-25.92%2Neutral-25.9% tokenization collapse; a broken IPO with no floor in sight — stay away
Stock Brief 2026-07-08: Daily U.S. & HK Market Analysis Archive · Quant Brief